NA 398.811Recalls & reported problems
Synthes GmbH · PLATE HOLDING FORCEPS WITH SWIVEL FOOT/SIZE 0 · Class 1
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 10886982201676), received between May 29, 2019 and May 29, 2019 — classified as 1 malfunction.
The most frequently reported specific device problem is “Break” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.
Most reported problems
Device problems
- Break1
Patient problems
- No Patient Involvement1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
MalfunctionMay 29, 2019Break; Break
IT WAS REPORTED THAT ON AN UNKNOWN DATE, THE PLATE HOLDING FORCEPS WITH SWIVEL FOOT WAS FOUND BROKEN UPON OPENING THE PACKAGE AT THE HOSPITAL. THE SWIVEL FOOT WAS NOT ATTACHED TO THE FORCEPS. IT APPEARS TO BE MISSING THE PIN THAT HOLDS IT IN PLACE. THIS ITEM HAS NOT BEEN USED OR STERILIZED. THERE WAS NO PATIENT INVOLVEMENT. THIS REPORT IS FOR A PLATE HOLDING FORCEPS. THIS IS REPORT 1 OF 1 FOR (B)(4).
Patient problems: No Patient Involvement
MAUDE report 8650063 ↗
Other FORCEPS devices
- NA 314.291Synthes GmbH · FORCEPS177 reports
- NA 399.99Synthes GmbH · FORCEPS111 reports
- NA PDL114Synthes GmbH · FORCEPS81 reports
- GEM COUPLER Forceps GEM4183CSynovis Micro Companies Alliance, Inc · FORCEPS1 recall4 reports
- AESCULAP BJ025RAesculap AG · FORCEPS1 recall0 reports
- AESCULAP BJ058RAesculap AG · FORCEPS1 recall0 reports
- AESCULAP BJ062RAesculap AG · FORCEPS1 recall0 reports
- ATRAUMATA FB440RAesculap AG · FORCEPS1 recall0 reports
Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.